CLINICAL_TRIALS
trial_result
· 2025-10-21
Clinical Trial Update: A Study of Tirzepatide (LY3298176) in Chinese Participants With Type 2 Diabetes (SURPASS-CN-MONO) [Phase 3]
Summary
A Phase 3 trial of tirzepatide (LY3298176) in Chinese participants with Type 2 Diabetes has completed, and results have been posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Eli Lilly and Company | Conditions: Type 2 Diabetes | Phase 3 | Status: COMPLETED | Results posted: 2025-10-21